Paul G. Abrams
Directeur/Bestuurslid bij Geneius Biotechnology, Inc.
Profiel
Paul G.
Abrams is currently the Executive Director at Geneius Biotechnology, Inc. He was previously the President & Chief Executive Officer at Poniard Pharmaceuticals, Inc. from 1990 to 2001.
He also served as the President & Chief Executive Officer at CEPTYR, Inc.
Actieve functies van Paul G. Abrams
| Bedrijven | Functie | Begin |
|---|---|---|
Geneius Biotechnology, Inc.
 Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Geneius Biotechnology, Inc. operates as an immuno-oncology company. It develops autologous, adoptive T cell therapy technology which generates robust immune response to cancer. The company was founded by Alfred E. Slanetz in 2015 and is headquartered in Natick, MA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Paul G. Abrams
| Bedrijven | Functie | Einde |
|---|---|---|
| PONIARD PHARMACEUTICALS, INC. | Algemeen Directeur | 31-07-2001 |
CEPTYR, Inc.
 CEPTYR, Inc. Pharmaceuticals: MajorHealth Technology CEPTYR, Inc. developed pharmaceutical products. The company was founded by George Rathmann & Deborah Cool in 1995 and was headquartered in Redmond, WA. | President | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
CEPTYR, Inc.
CEPTYR, Inc. Pharmaceuticals: MajorHealth Technology CEPTYR, Inc. developed pharmaceutical products. The company was founded by George Rathmann & Deborah Cool in 1995 and was headquartered in Redmond, WA. | Health Technology |
Geneius Biotechnology, Inc.
Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Geneius Biotechnology, Inc. operates as an immuno-oncology company. It develops autologous, adoptive T cell therapy technology which generates robust immune response to cancer. The company was founded by Alfred E. Slanetz in 2015 and is headquartered in Natick, MA. | Commercial Services |
